4. This section does not limit the power of a corporation to acquire, in whole or in part, the shares of one or more classes or series of another company through voluntary exchange or other means. [Fla. Stat. No. 607.1102] This final share exchange agreement („agreement“) of June 29, 2020 is part of Futuris Technology Services, Inc. („Futuris“), a Virginia-based company at 4506 Daly Drive, Suite-100, Chantilly VA 20151 (the sole owner of Pioneer Global Inc., a Virginia company („Pioneer“), the shareholders of Futuris (together the „shareholders“) and Mission Mining Co., a Wyoming company („MISM“) located on Baltimore Road 22. , Rockville, MD 20850, and Kalyan Pathuri, President of MISM („Pathuri“). Together, the shareholders, Futuris, MISM and Pathuri are the „parties“. The term „stock exchange“ is used in the rarest circumstances of an employee who wishes to exercise his stock options and convert them into shares.
An employee who was a co-founder or former purchaser of a successful start-up might find that he or she has the opportunity to buy a lot of shares, but that the money needed to buy these shares is prohibitive. Under these conditions, the employee can use the value of the shares already held to pay for the new shares. Instead of selling these shares to raise the money to exercise the option, the worker simply exchanges the shares to pay for the exercise of many more shares. Share swets may represent all counterparties paid into a wholesale funds agreement; they may be part of a merger agreement with a cash payment to the shareholders of the target company, or they can be calculated for both Denacquirer and the purpose of a newly created business. This SHARE EXCHANGE AGREEMENT (the „agreement“) will be concluded on August 10, 2016 by and between CORRECTIVE BIOTECHNOLOGIES, INC., a Wyoming company („Biotechnologies“), with offices in 605 W. Knox Rd., Suite 202 Tempe, AZ 85284, BIOMODELING SOLUTIONS, INC., an Oregon company with offices in 17933 NW Evergreen Pkwy., Suite 280 Beaverton, OR 97006 („BioModeling“), BioModeling shareholders listed on the signature page , FIRST VIVOS, INC., a Texas-based company with offices in 514 Country Lane, Coppell, TX 75019 („Vivos“) and vivo shareholders, „Vivos shareholders“ under the following conditions (BioModeling and Vivos are collectively referred to as „acquired companies“): in accordance with the terms of the stock exchange agreement, the company has agreed to acquire a 100% interest in IEGC for 272,447,137 common shares of the company after having a 1 for 6 fraction shares.